ストックスクリーナーアプリを入手
91.26
1.02%
0.92
前日終値:
$90.34
開ける：
$90.61
24時間の取引高:
1.33M
Relative Volume:
5.05
時価総額：
$907.13M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+3.83%
1か月 パフォーマンス:
+5.78%
6か月 パフォーマンス:
-6.34%
1年 パフォーマンス:
+2.54%
1日の値動き範囲:
$90.51
$91.48
1週間の範囲:
$88.46
$91.48
52週間の値動き範囲:
$84.48
$99.51
Vaneck Pharmaceutical Etf Stock (PPH) Company Profile
PPH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PPH
Vaneck Pharmaceutical Etf
|
91.26 | 907.13M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
295.92 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
599.94 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
602.87 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
239.61 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
526.08 | 124.43B | 0 | 0 | 0 | 0.00 |
Vaneck Pharmaceutical Etf (PPH) 最新ニュース
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? - MSN
Cencora Stock Outlook: Is Wall Street Bullish or Bearish? - TradingView
DeepSeek’s Disruption: The Impact on Nvidia and the Semiconductor Industry - VanEck
How to profit from AI innovation in 2025 - Equities News
Is Wall Street Bullish or Bearish on AbbVie Stock? - Inkl
The Investment Case for Bitcoin - VanEck
2025 Semiconductor Outlook: Investor Roadmap - VanEck
JPMorgan Chase & Co. Has $907,000 Stake in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Barclays PLC Sells 3,263 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? - MSN
Is Investing in the WisdomTree Cloud Computing ETF (WCLD) a Smart Move - espeaks.co.uk
Gold in 2024: Central Bank Demand, Rising Prices and the Equity Disconnect - VanEck
Eli Lilly Cuts Q4 Sales Forecast: ETFs to Buy on the Dip - MSN
Is Investing in the Invesco Semiconductors ETF (PSI) a Smart Move - espeaks.co.uk
What Trump's Presidency Will Mean for Bitcoin - VanEck
Tech Investing in 2025: Emerging Trends and Market Opportunities - VanEck
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - Yahoo Canada Finance
Annual ETF Highlights: A Dive Into the Best and Worst of 2024 - VanEck
Eli Lilly Cuts Q4 Sales Forecast: ETFs To Buy On The Dip - Barchart
Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025 - Seeking Alpha
Taking a Look Under the Hood of VanEck’s Video Gaming and Esports Strategy - VanEck
Sanctuary Advisors LLC Sells 41,736 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Acquired by Jane Street Group LLC - Defense World
Stifel Financial Corp Has $742,000 Holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
MML Investors Services LLC Decreases Position in Five Below, Inc. (NASDAQ:FIVE) - Defense World
MML Investors Services LLC Has $362,000 Position in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
VanEck Mortgage REIT Income ETF (NYSEARCA:MORT) Shares Sold by Stifel Financial Corp - Defense World
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? - MSN
World Equal Weight ETF | TSWE - VanEck
Broad Market Gains Shape Moat Strategies for 2025 - VanEck
Fmr LLC Buys 212 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
PPH Is a Pertinent Healthcare Idea for 2025 - ETF Trends
VanEck’s 10 Crypto Predictions for 2025 - VanEck
Three Forces Powering the Nuclear Energy Surge - VanEck
Bank of Montreal Can Grows Position in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
The Inflation Reduction Act: A Green Catalyst - VanEck
Winners And Losers: Post-Election Options Analysis - Barchart
A Better Way to Equal Weight? - VanEck
Big Pharma earnings season in spotlight amid positive sentiment - MSN
VanEck Mid-November Bitcoin ChainCheck - VanEck
Investment Opportunities in SMRs: The Future of Nuclear Power - VanEck
Are Wall Street Analysts Predicting Cencora Stock Will Climb or Sink? - MSN
October Gold Rally and Key Earnings Insights - VanEck
VanEck Pharmaceutical ETF (NASDAQ:PPH) Sees Strong Trading Volume – Time to Buy? - Defense World
Vaneck Pharmaceutical Etf (PPH) 財務データ
Vaneck Pharmaceutical Etf (PPH) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
1.15%
大文字化:
|
ボリューム (24 時間):